Skip to content
Recall Observatory FDA recall evidence

Drug product

Labetalol HCl Injection, USP, 20 mg/4 mL (5 mg/mL) syringe, packaged in 5 x 4 mL Pre-Filled Syringes per carton, 6 x 5 Syringe Carton per case, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-946-04

D-1262-2022

June 30, 2022

Class II

Product summary

Firm
Nephron Sterile Compounding Center LLC
Event
Event 90512
Status
Terminated
Classification
Class II
Quantity
184,370 syringes
Official record key
drug-enforcement:D-1262-2022

Official wording

Reason: Lack of Assurance of Sterility

Code information: Lots: LB2002A, Exp. 7/12/2022; LB2004A, Exp. 8/21/2022; LB2006A, Exp. 9/3/2022; LB2008A, Exp. 10/6/2022

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility